The Impact of HIV on the Prevalence of Asthma in Uganda: a General Population Survey

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2018 Sep 23

PMID 30241519

Citations 9

Authors

Bruce J Kirenga

Levicatus Mugenyi

Corina de Jong

J Lucian Davis

Winceslaus Katagira

Thys van der Molen

Moses R Kamya

Marike Boezen

Affiliations

Soon will be listed here.

Abstract

Background: HIV and asthma are highly prevalent diseases in Africa but few studies have assessed the impact of HIV on asthma prevalence in high HIV burden settings. The objective of this analysis was to compare the prevalence of asthma among persons living with HIV (PLHIV) and those without HIV participating in the Uganda National Asthma Survey (UNAS).

Methods: UNAS was a population-based survey of persons aged ≥12 years. Asthma was diagnosed based on either self-reported current wheeze concurrently or within the prior 12 months; physician diagnosis; or use of asthma medication. HIV was defined based on confidential self-report. We used Poisson regression with robust standard errors to estimate asthma prevalence and the prevalence ratio (PR) for HIV and asthma.

Results: Of 3416 participants, 2067 (60.5%) knew their HIV status and 103 (5.0%) were PLHIV. Asthma prevalence was 15.5% among PLHIV and 9.1% among those without HIV, PR 1.72, (95%CI 1.07-2.75, p = 0.025). HIV modified the association of asthma with the following factors, PLHIV vs. not PLHIV: tobacco smoking (12% vs. 8%, p = < 0.001), biomass use (11% vs. 7%, p = < 0.001), allergy (17% vs. 11%, p = < 0.001), family history of asthma (17% vs. 11%, p = < 0.001), and prior TB treatment (15% vs. 10%, p = < 0.001).

Conclusion: In Uganda the prevalence of asthma is higher in PLHIV than in those without HIV, and HIV interacts synergistically with other known asthma risk factors. Additional studies should explore the mechanisms underlying these associations. Clinicians should consider asthma as a possible diagnosis in PLHIV presenting with respiratory symptoms.

Citing Articles

A Descriptive Analysis of Nasal Polyposis in HIV Positive Versus HIV Negative Patients.

Molokomme T, Maharaj S, Motakef S Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3289-3297.

PMID: 39130228 PMC: 11306855. DOI: 10.1007/s12070-024-04674-z.

Re-estimation of the burden of serious fungal diseases in Uganda.

Bongomin F, Kwizera R, Namusobya M, van Rhijn N, Andia-Biraro I, Kirenga B Ther Adv Infect Dis. 2024; 11:20499361241228345.

PMID: 38328511 PMC: 10848809. DOI: 10.1177/20499361241228345.

HIV-associated lung disease.

Konstantinidis I, Crothers K, Kunisaki K, Drummond M, Benfield T, Zar H Nat Rev Dis Primers. 2023; 9(1):39.

PMID: 37500684 PMC: 11146142. DOI: 10.1038/s41572-023-00450-5.

Circadian-Coupled Genes Expression and Regulation in HIV-Associated Chronic Obstructive Pulmonary Disease (COPD) and Lung Comorbidities.

Panda K, Chinnapaiyan S, Rahman M, Santiago M, Black S, Unwalla H Int J Mol Sci. 2023; 24(11).

PMID: 37298092 PMC: 10253051. DOI: 10.3390/ijms24119140.

Health conditions in adults with HIV compared with the general population: A population-based cross-sectional analysis.

Morales D, Moreno-Martos D, Matin N, McGettigan P EClinicalMedicine. 2022; 47:101392.

PMID: 35497059 PMC: 9046106. DOI: 10.1016/j.eclinm.2022.101392.

References

Lin R, Lazarus T . Asthma and related atopic disorders in outpatients attending an urban HIV clinic. Ann Allergy Asthma Immunol. 1995; 74(6):510-5. View

Thuesen B, Husemoen L, Hersoug L, Pisinger C, Linneberg A . Insulin resistance as a predictor of incident asthma-like symptoms in adults. Clin Exp Allergy. 2009; 39(5):700-7. DOI: 10.1111/j.1365-2222.2008.03197.x. View

George M, Kannass M, Huang L, Sciurba F, Morris A . Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One. 2009; 4(7):e6328. PMC: 2709444. DOI: 10.1371/journal.pone.0006328. View

Doffman S, Miller R . Interstitial lung disease in HIV. Clin Chest Med. 2013; 34(2):293-306. DOI: 10.1016/j.ccm.2013.01.012. View

Mdege N, Shah S, Ayo-Yusuf O, Hakim J, Siddiqi K . Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries. Lancet Glob Health. 2017; 5(6):e578-e592. PMC: 5439027. DOI: 10.1016/S2214-109X(17)30170-5. View

Ayles H, Muyoyeta M, Du Toit E, Schaap A, Floyd S, Simwinga M . Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet. 2013; 382(9899):1183-94. DOI: 10.1016/S0140-6736(13)61131-9. View

Adeloye D, Chan K, Rudan I, Campbell H . An estimate of asthma prevalence in Africa: a systematic analysis. Croat Med J. 2014; 54(6):519-31. PMC: 3893990. DOI: 10.3325/cmj.2013.54.519. View

Kendall C, Wong J, Taljaard M, Glazier R, Hogg W, Younger J . A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario. BMC Public Health. 2014; 14:161. PMC: 3933292. DOI: 10.1186/1471-2458-14-161. View

Gingo M, Morris A . Pathogenesis of HIV and the lung. Curr HIV/AIDS Rep. 2012; 10(1):42-50. PMC: 3567220. DOI: 10.1007/s11904-012-0140-x. View

10.

Kidd P . Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003; 8(3):223-46. View

11.

. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J. 1998; 12(2):315-35. DOI: 10.1183/09031936.98.12020315. View

12.

Marais B . Childhood tuberculosis: epidemiology and natural history of disease. Indian J Pediatr. 2011; 78(3):321-7. DOI: 10.1007/s12098-010-0353-1. View

13.

Deo S, Mistry K, Kakade A, Niphadkar P . Role played by Th2 type cytokines in IgE mediated allergy and asthma. Lung India. 2010; 27(2):66-71. PMC: 2893428. DOI: 10.4103/0970-2113.63609. View

14.

Rohr J, Gomez-Olive F, Rosenberg M, Manne-Goehler J, Geldsetzer P, Wagner R . Performance of self-reported HIV status in determining true HIV status among older adults in rural South Africa: a validation study. J Int AIDS Soc. 2017; 20(1):21691. PMC: 5577734. DOI: 10.7448/IAS.20.1.21691. View

15.

Gingo M, Wenzel S, Steele C, Kessinger C, Lucht L, Lawther T . Asthma diagnosis and airway bronchodilator response in HIV-infected patients. J Allergy Clin Immunol. 2011; 129(3):708-714.e8. PMC: 3294124. DOI: 10.1016/j.jaci.2011.11.015. View

16.

Semenzato G, Agostini C . HIV-related interstitial lung disease. Curr Opin Pulm Med. 1995; 1(5):383-91. View

17.

Lee C, Kim K, Hyun M, Jang E, Lee N, Yim J . Use of inhaled corticosteroids and the risk of tuberculosis. Thorax. 2013; 68(12):1105-13. DOI: 10.1136/thoraxjnl-2012-203175. View

18.

To T, Stanojevic S, Moores G, Gershon A, Bateman E, Cruz A . Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012; 12:204. PMC: 3353191. DOI: 10.1186/1471-2458-12-204. View

19.

Drummond M, Merlo C, Astemborski J, Kalmin M, Kisalu A, McDyer J . The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS. 2013; 27(8):1303-11. PMC: 3953568. DOI: 10.1097/QAD.0b013e32835e395d. View

20.

Crothers K, Huang L, Goulet J, Goetz M, Brown S, Rodriguez-Barradas M . HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2010; 183(3):388-95. PMC: 3266024. DOI: 10.1164/rccm.201006-0836OC. View